Can-Fite BioPharma Ltd. Interest Expense 2011-2026 | CANF

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Can-Fite BioPharma Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	227 K	-304 K	-618 K	-1.15 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
227 K	-1.15 M	-462 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	-133 K	$ 20.36	-1.64 %	$ 2.57 B	USA
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Axsome Therapeutics AXSM	-15.9 M	$ 164.64	-1.05 %	$ 8.19 B	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
AbCellera Biologics ABCL	-2.71 M	$ 3.7	-3.27 %	$ 1.11 B	Canada
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
Certara CERT	6.34 M	$ 7.28	3.19 %	$ 1.17 B	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	399 K	$ 26.28	-2.16 %	$ 704 M	USA
Codexis CDXS	-10.4 M	$ 1.01	-0.49 %	$ 74.1 M	USA
Catalyst Pharmaceuticals CPRX	25.7 M	$ 23.89	0.04 %	$ 2.92 B	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	1.26 M	$ 3.22	-3.59 %	$ 1.15 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	1.96 M	$ 28.92	-0.96 %	$ 1.68 B	USA
Champions Oncology CSBR	73 K	$ 5.98	-1.48 %	$ 81.7 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	371 K	$ 3.68	-3.16 %	$ 116 M	France
Alector ALEC	13.2 M	$ 2.13	-3.62 %	$ 219 M	USA
KalVista Pharmaceuticals KALV	4.81 M	$ 15.77	-1.81 %	$ 783 M	Britain
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	685 K	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	48 K	$ 4.25	2.04 %	$ 302 M	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	7 K	$ 14.2	1.9 %	$ 5.89 B	Irlanda